SQ-LIP-000018 · v1.2 (archived) · View current version →
How does lipedema relate to varicose veins and venous disease?
Based on currently indexed evidence, lipedema and varicose veins frequently coexist clinically: a cross-sectional study found 45.1% of lipedema patients had varicose veins, and a two-case report from India documented bilateral varicose veins in both lipedema patients presented. Because varicose veins are common in women (~49%) and lipedema affects ~11%, a substantial proportion of women undergoing venous ultrasound for varicose veins may have coexisting lipedema, making the venous exam a potential opportunity for lipedema screening (low-grade evidence). At the mechanistic level, lipedema is associated with a microangiopathy featuring increased capillary permeability, plasma VEGF roughly 4-fold above normal, and capillary fragility (a systematic review noted 13.95 petechiae pre-CDT reduced to 8.78 post-CDT, P<0.001). However, a moderate-grade cross-sectional study found elevated serum VEGF-C and increased M2/CD163+ macrophage infiltration WITHOUT corresponding morphological changes in lymphatic or blood vessels, indicating that lipedema's molecular vascular changes do not appear to produce overt structural venous disease and that lipedema is distinguished from venous and lymphatic disease diagnostically (negative Stemmer sign, foot-sparing 'cuffing' sign). A National Inpatient Sample analysis examined venous thromboembolic outcomes in patients with lymphedema and lipedema, though its findings remain unclassified in the current evidence base. Overall, varicose veins co-occur with lipedema and venous assessment may aid screening, but the co-occurrence data are low to very low quality, and the higher-quality vascular biology evidence suggests lipedema does not itself generate overt structural venous disease.
Knowledge freshness = share of the 5 indexed evidence sources from the last 5 years (newest 2025, oldest 2012) . Low freshness flags an ageing evidence base — not that the answer is wrong.
Evidence over time
supporting contradicting refining / context Each dot is a study, placed by year and coloured by whether the linked claim supports or contradicts the answer. As the surveillance loop runs, claim revisions and new evidence will extend this timeline. The hollow ring marks the first time this topic appears in the literature.
Choose a format (Vancouver default). Citing a version captures the evidence state on that date; this page shows the current version — see version history.
What changed in this version
This update added a systematic review characterizing lipedema's microangiopathy (increased capillary permeability, ~4-fold elevated plasma VEGF, capillary fragility) and diagnostic features distinguishing it from venous/lymphatic disease, while confirming no direct quantification of a lipedema–varicose vein association.
Supporting claims
- SCR-LIP-000013 supporting
Because ~49% of women have varicose veins and ~11% have lipedema, a substantial proportion of women undergoing venous ultrasound for varicose veins also have coexisting lipedema, making the venous exam an opportunity for lipedema screening.
Ultrasound criteria for lipedema diagnosis — Amato et al. (2021) - SCR-LIP-000131 supporting
Both reported lipedema cases presented with bilateral varicose veins alongside characteristic disproportionate subcutaneous fat distribution, consistent with a described association between lipedema and varicose veins in the literature.
Report of two cases of lipedema: An under-recognized, misdiagnosed, and under-reported disorder in India — Kuttiatt et al. (2025)
Contradictory claims
- None indexed yet.
Refining / context
- SCR-LIP-000132 refines
Lipedema patients show elevated serum VEGF-C and increased macrophage infiltration (predominantly M2/CD163+) without corresponding morphological changes in lymphatic or blood vessels, distinguishing lipedema from lymphedema and suggesting the vascular changes do not produce clinical lymphedema or overt venous disease.
Increased levels of VEGF-C and macrophage infiltration in lipedema patients without changes in lymphatic vascular morphology — Felmerer et al. (2020) - SCR-LIP-000133 context
Venous thromboembolic outcomes in patients with lymphedema and lipedema: An analysis from the National Inpatient Sample
Venous thromboembolic outcomes in patients with lymphedema and lipedema: An analysis from the National Inpatient Sample — Khalid et al. (2024) - SCR-LIP-000166 context
This systematic review describes lipedema diagnostic criteria distinguishing it from venous and lymphatic disease (negative Stemmer sign, foot-sparing 'cuffing' sign) and reports a microangiopathy with increased capillary permeability, plasma VEGF approximately 4-fold above normal, and capillary fragility (13.95 petechiae pre-CDT reduced to 8.78 post-CDT, P<0.001), but does not directly quantify an association between lipedema and varicose veins.
Lipedema: an overview of its clinical manifestations, diagnosis and treatment of the disproportional fatty deposition syndrome – systematic review — Forner‐Cordero et al. (2012)
Major uncertainty
Whether lipedema causally contributes to venous disease or merely co-occurs remains unresolved: co-occurrence prevalence data are low to very low quality (one cross-sectional study, one two-case report), while the higher-quality molecular/morphological evidence indicates no structural venous abnormality, and venous thromboembolic outcome data from the National Inpatient Sample remain unclassified.
Version history
- SQ-LIP-000018 · v1.2 — 2026-05-31 — This update added a systematic review characterizing lipedema's microangiopathy (increased capillary permeability, ~4-fold elevated plasma VEGF, capillary fragility) and diagnostic features distinguishing it from venous/lymphatic disease, while confirming no direct quantification of a lipedema–varicose vein association. · view this version
- SQ-LIP-000018 · v1.1 — 2026-05-31 — This update added two case reports documenting bilateral varicose veins in lipedema patients, a moderate-grade vascular biology study showing no morphological blood vessel changes despite elevated VEGF-C in lipedema (refining the mechanistic picture), and a National Inpatient Sample study on venous thromboembolic outcomes in lipedema/lymphedema patients (currently unclassified), collectively deepening but also complicating the understanding of the lipedema–venous disease relationship. · view this version
- SQ-LIP-000018 · v1.0 — 2026-05-30 — founding index (5 claims) · view this version
Key references
DOI:10.1177/02683555211002340 · DOI:10.4103/jpgm.jpgm_273_25 · DOI:10.1038/s41598-020-67987-3 · DOI:10.1177/1358863x231219006 · DOI:10.1111/j.1758-8111.2012.00045.x